OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
Yo-Ting Tsai, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Yo-Ting Tsai, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Dynamic changes in peripheral blood immunophenotyping and its prognostic value in cervical cancer patients undergoing immune checkpoint blockade therapy
Wenjian Gong, Zhi Wang, Yongqiang Wei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Wenjian Gong, Zhi Wang, Yongqiang Wei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Systemic Immune-Inflammation Index as a Predictor of Survival in Non-Small Cell Lung Cancer Patients Undergoing Immune Checkpoint Inhibition: A Systematic Review and Meta-Analysis
Ye Zhang, Yeye Chen, Chao Guo, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104669-104669
Closed Access
Ye Zhang, Yeye Chen, Chao Guo, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104669-104669
Closed Access
Validation of machine learning application for the identification of lipid metabolism-associated diagnostic model in ischemic stroke
Xiangtian Meng, Runping Xu, Haoheng Wang, et al.
International Journal of Clinical and Experimental Pathology (2025) Vol. 18, Iss. 2, pp. 63-76
Closed Access
Xiangtian Meng, Runping Xu, Haoheng Wang, et al.
International Journal of Clinical and Experimental Pathology (2025) Vol. 18, Iss. 2, pp. 63-76
Closed Access
CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer Immunotherapy
Rosaely Casalegno‐Garduño, Alf Spitschak, Tim Pannek, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 930-930
Open Access
Rosaely Casalegno‐Garduño, Alf Spitschak, Tim Pannek, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 930-930
Open Access
Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Exploring the Roles of Key Mediators IKBKE and HSPA1A in Alzheimer’s Disease and Hepatocellular Carcinoma through Bioinformatics Analysis
Yiying Wang, Yakun Yang, Ce Liang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6934-6934
Open Access | Times Cited: 1
Yiying Wang, Yakun Yang, Ce Liang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6934-6934
Open Access | Times Cited: 1
Nivolumab plus ipilimumab with chemotherapy in metastatic NSCLC: minireview and a case study of a patient negative for PD-L1
Alessandro Morabito
Drugs in Context (2024) Vol. 13, pp. 1-8
Open Access | Times Cited: 1
Alessandro Morabito
Drugs in Context (2024) Vol. 13, pp. 1-8
Open Access | Times Cited: 1
Circulating Interleukins as Biomarkers in Non-Small Cell Lung Cancer Patients: A Pilot Study Compared to Normal Individuals
Wei‐Wen Lim, Jason H. Leung, Chen Xie, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 221-221
Open Access | Times Cited: 1
Wei‐Wen Lim, Jason H. Leung, Chen Xie, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 221-221
Open Access | Times Cited: 1
Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer
Mengjie Zhang, Jian Wu, Yongxin Zhang, et al.
Annals of Surgical Oncology (2024)
Closed Access
Mengjie Zhang, Jian Wu, Yongxin Zhang, et al.
Annals of Surgical Oncology (2024)
Closed Access
Integrate analysis of bulk and single-cell RNA sequencing demonstrates a transcriptional pattern characterized by GDF15 of tumor cells that predicts immunotherapy efficacy in non-small cell lung cancer
Xianfei Zhang, Z. S. Yin, Xueyu Chen, et al.
Research Square (Research Square) (2024)
Open Access
Xianfei Zhang, Z. S. Yin, Xueyu Chen, et al.
Research Square (Research Square) (2024)
Open Access
Melanoma’s New Frontier: Exploring the Latest Advances in Blood-Based Biomarkers for Melanoma
Ivana Prkačin, Mislav Mokos, Nikola Ferara, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4219-4219
Open Access
Ivana Prkačin, Mislav Mokos, Nikola Ferara, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4219-4219
Open Access
Biomarkers for immunotherapy resistance in non-small cell lung cancer
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access
